Dear Reader,
Before Bear Stearns collapsed … Lehman Brothers went bankrupt … and Washington Mutual became the largest bank failure in American history …
Our company Weiss Ratings was already warning investors about these risks.
Unfortunately, by the time most Americans realized how serious the problem was, the financial crisis was already upon us and much of the damage was already done.
That’s why we’re speaking out today.
The founder of Weiss Ratings, Martin Weiss, a Wall Street Journal, BusinessWeek and New York Times best-selling author …
Has been running Weiss Ratings as a 100% conflict-free, independent financial rating agency for 55 years.
And during those 55 years, he’s publicly warned investors before six major American crashes.
Right now, he believes another dangerous credit crisis is building beneath the surface.
Banks … insurance companies and annuities … investment funds and retirement portfolios could all feel the effects if it spreads.
However, many Americans don’t realize how exposed their money already is.
Don’t make that mistake.
That’s why he’s laid out five specific steps you can take now to help protect your wealth before this new crisis spreads.
The first step alone could help you identify where your money could be vulnerable. And the remaining steps show you what he believes you should consider doing with your money instead.
Please don’t wait for another Lehman-style headline before you take this seriously.
See Martin’s warning and the five steps he recommends taking now
Sincerely,
Eliza Lasky
Weiss Advocate
Corteva Fell 6% Overnight. Here Is What the Gap Tells Traders.
When a company completes a major restructuring and then immediately misses its first solo earnings report, the market does not wait for a conference call to respond. Corteva stock slid 6.4% in after-hours trading to reach $11.36 after the company reported its first set of quarterly results as a pure-play crop protection company, delivering figures that fell short of Wall Street’s expectations on both the top and bottom lines. That overnight drop is not noise. It is information, and active traders need to know how to read it.
What Happened
On October 1, 2026, Corteva completed the spin-off of its seed operating segment into Vylor Inc. through a pro rata distribution to holders of record as of the close of business on September 24, 2026. Seeds had generated around 66% of profits in 2025, with the remaining 34% coming from crop protection. So Wednesday’s report was the first genuine look at what the remaining business actually earns without the seed segment propping up the numbers.
The answer was not encouraging. Third-quarter net sales came in at $1.591 billion, a 9% decline year-over-year, while the company swung to a pro forma GAAP continuing-operations loss of $54 million compared to income of $60 million in the same period a year earlier. Volume declined 2% year-over-year, pricing fell 7% driven by competitive pressure on molecules late in their lifecycle in Brazil and U.S. acetochlor, and Latin America organic sales plunged 31%, with volumes down 24% due to elevated channel inventory and delayed purchasing.
Correction: Adjusted pro forma operating EBITDA for Q3 was $222 million, down 17% compared to the prior year, translating into 140 basis points of margin erosion. For a business now valued entirely on crop-protection fundamentals, margin erosion in the first quarter as a standalone entity is about the worst possible signal management could have sent.
Why It Happened
Brazil is the proximate cause, but the problem runs deeper. Adjusted operating EBITDA guidance of $1.1 billion to $1.125 billion reflects weaker market conditions in Brazil, where farmer liquidity constraints and elevated financing costs have created a softer market than previously anticipated. That is a demand problem, not a supply-chain fix that resolves in a quarter.
The broader crop-protection sector offers no cover. The split between seed and crop-protection businesses was stark in Q3 2026 agribusiness results across the industry, with EBITDA margins at several majors under severe pressure. Ahead of the report, analysts had already trimmed their EPS consensus estimate by roughly 7% over the prior 30 days, and UBS had lowered its price target on the stock, reflecting cautious sentiment around the newly independent crop-protection entity. The street expected weakness. The numbers were still worse.
How Professionals Might View It
Experienced traders treat post-spinoff gaps with more respect than most people realize. When a company separates, the shareholder base immediately becomes mismatched: index funds that owned the parent may not want the smaller stub, and retail holders often sell the unfamiliar name without doing the work. That forced selling often overstates the fundamental damage in the first days. But it can also persist longer than it should if the fundamental story keeps deteriorating.
Post-spinoff shareholder dislocation compounds a dynamic familiar from other agricultural equipment names. Deere’s beat-and-fall earnings pattern shows how a stock priced for a prior business mix can punish holders even when headline numbers look acceptable.
The Corteva situation leans toward the latter. A revenue miss, a swing to a GAAP operating loss, a guidance reduction tied to Brazil, and the added uncertainty of operating as a newly independent business for the first time all converged to push Corteva shares toward their 52-week low of $11.25. A disciplined trader does not fade that kind of gap on day one. The question is not whether the stock is cheap relative to where it traded before the spinoff; the question is whether the new price reflects the new earnings power. Wednesday’s numbers make that harder to answer confidently.
Peers like FMC and Bayer Crop Science provide context. Both have been navigating the same Brazil headwinds and generic pricing pressure in crop protection chemistry throughout 2026. Neither has found the problem solved quickly. That sector-level pressure matters when setting expectations for how long Corteva’s recovery timeline might be.
What Comes Next
The conference call Thursday morning at 10:30 a.m. Eastern is the first real test. Management’s explanation of the Brazil deterioration and any color on Q4 channel restocking will either stabilize the gap or extend it. Watch the EBITDA guidance range closely: reflecting market dynamics, primarily the deterioration in Brazil, the company updated its full-year 2026 guidance, with adjusted pro forma operating EBITDA now expected between $1.1 billion and $1.125 billion. Any revision to that band would be meaningful.
Traders focused on relative strength should also watch Vylor. The seed business that left carried the higher-margin operations, and if Vylor holds up while CTVA gaps lower, that relative divergence is data about where institutional capital is repositioning.
The Trader’s Lesson
Post-spinoff gaps are not the same as ordinary earnings gaps. The shareholder base is artificially unstable, the valuation framework is unproven, and there is no historical comparable in the new form. That combination can produce both violent overshoots to the downside and misleading bounces. The disciplined response is patience: let price stabilize, let institutional holders who want the name accumulate, and require confirmation before taking a position either direction. A stock down 6% overnight on its first independent earnings report has not yet earned the benefit of the doubt.